News
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
A new obesity pill, Orforglipron, shows promise in weight loss trials. Eli Lilly reports that patients lost around 12% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback